What is Valcyte?
Valcyte® (valganciclovir hydrochloride) is an antiviral medicine that helps prevent cytomegalovirus (CMV).*
How should I take Valcyte?
- Take Valcyte exactly as your doctor prescribes it
- Adult patients should use Valcyte tablets, not Valcyte for oral solution
- Take Valcyte with food
- Do not break or crush tablets
How long will I need to take Valcyte?
Your doctor prescribed Valcyte for the length of time needed to help prevent CMV disease based on the type of transplant you have received.
- Adult heart or kidney-pancreas transplant patients may take Valcyte for up to 100 days after transplant. Adult kidney transplant patients may take Valcyte for up to 200 days after transplant
- Pediatric patients who have received a heart or kidney transplant may take Valcyte for up to 100 days after transplant
My healthcare provider said my dose of Valcyte may go up or down. Why?
The dose of Valcyte is based on a laboratory measurement of how well your kidneys are working (kidney function). No matter what type of transplant you have received, your kidney function may change after your transplant. For this reason, your healthcare provider may schedule follow-up laboratory tests to monitor your dose of Valcyte and change your dosage if necessary.
What are the most common side effects from Valcyte?
Common side effects of Valcyte in adults and children include:
- Shaky movements (tremors)
- Low blood cell counts in a blood test
- Rejection of the transplanted organ (graft)
Common side effects specifically in children include:
- High blood pressure
- Cough and colds
Call your healthcare provider if you experience side effects or if you have questions about your Valcyte medicine. You may report side effects to the FDA at 1-800-FDA-1088 or to Genentech at 1-888-835-2555.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "Proceed" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech, Inc. does not recommend and does not endorse the content on any third-party Web sites. Your use of third-party Web sites is at your own risk and subject to the terms and conditions of use for such sites.
In order to qualify for the Valcyte® Co-pay Card, the patient may be required to pay certain out-of-pocket expenses for each treatment. The Co-pay Card program is not valid for patients whose prescription drugs are covered, in whole or in part, under Medicaid, Medicare, or any other state or federal healthcare program. Patient or guardian is responsible for reporting the receipt of all co-pay benefits or reimbursement received, to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the Co-pay Card program. This card is not health insurance or a benefit plan. You must be 18 years or older to receive co-pay assistance for yourself or a minor. This Co-pay Card program is void if the card is reproduced and where prohibited by law. It is good only for Genentech products in the U.S. and Puerto Rico. The Co-pay Card program expires within 12 months from enrollment. Company reserves the right to rescind, revoke, or amend the program without notice at any time. Patient, guardian, pharmacist, prescriber and any other person using the Co-pay Card agree not to seek reimbursement for all or any part of the benefit received by the recipient through the offer. Additional Terms & Conditions apply. Please visit www.Valcyte.com for the full list of Terms & Conditions.